CLINICAL_TRIALS
trial_result
· 2013-02-15
Clinical Trial Update: Combination of Temsirolimus and Bevacizumab in Patient With Metastatic Renal Cell Carcinoma [Phase 2]
Summary
A Phase 2 clinical trial evaluating the combination of temsirolimus and bevacizumab for metastatic renal cell carcinoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Centre Leon Berard | Conditions: Metastatic Renal Cell Carcinoma | Phase 2 | Status: COMPLETED